CSF1–CSF1R signaling sustains TAM viability and skews polarization; in proneural glioma models, CSF1R blockade remodels rather than depletes TAMs and attenuates tumor growth, highlighting circuitry that can be pharmacologically reprogrammed (11–13). Here, CSF1R is linked to central nervous system cancer.